Congress Will Hold A Hearing On Mylan's Big EpiPen Settlement With Justice Department
The less Mylan and the Justice Department say about their big settlement over EpiPen, the more Congress wants to hear about it.
The Senate Judiciary Committee will hold a hearing Nov. 30 to examine Mylan's agreement to pay the federal government $465 million to settle potential claims that the big drug company shortchanged Medicaid over rebates for sales of the anti-allergy EpiPen devices.
The hearing was called by committee chairman Sen. Chuck Grassley, R-Iowa. He is just one of several senators who has expressed frustration over the deal, with some calling for more disclosure about yet-to-be-signed agreement or for it to be scrapped altogether.
The Senate Judiciary Committee will hold a hearing Nov. 30 to examine Mylan's agreement to pay the federal government $465 million to settle potential claims that the big drug company shortchanged Medicaid over rebates for sales of the anti-allergy EpiPen devices.
The hearing was called by committee chairman Sen. Chuck Grassley, R-Iowa. He is just one of several senators who has expressed frustration over the deal, with some calling for more disclosure about yet-to-be-signed agreement or for it to be scrapped altogether.